Central Admixture Pharmacy Services Inc (CAPS) is recalling 66,961 units of various sterile injectable medications and intravenous bags due to a lack of assurance of sterility. The recall includes a wide range of medications such as Fentanyl, Ketamine, Phenylephrine, and Midazolam used in hospital and surgical environments. While no injuries or incidents have been reported, the sterility defect means the products may not be safe for patient administration. These products were distributed nationwide in the USA to hospitals, healthcare facilities, and pharmacies.
Medications intended for injection or intravenous use that are not guaranteed to be sterile pose a high risk of causing serious infections. Such infections can be life-threatening, particularly for surgery patients or those with compromised immune systems. To date, there have been no reported incidents or injuries associated with this recall.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.